Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Eisai Regains Full Control Of ADC Program After Bristol R&D Reprioritization
Jul 01 2024
•
By
Jessica Merrill
Eisai and Bristol ended an ADC collaboration • Source: Shutterstock
More from Deals
More from Business